1.
Atkinso
n MA and Eisenbarth GS: Type I diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221-229.
2.
DeFronz
o RA: Pathogenesis of Type 2 diabetes: metabolic and molecular
implications for identifying diabetes genes. Diabetes Review 1997; 5: 178-269.
3. The Diabetes Control and Complications Trial Research Group: The effect of intensive.
4. Treatment of diabetes on the development and progression of long-term
complications
i
n Insulin dependent diabetes mellitus. New England Journal of Medicine 1993; 329: 977-986.
5. The Diabetes
Contro
l and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with Type 1 diabetes four years after a trial of intensive therapy. New England Journal of Medicine 2000; 342:
381-389.
6.
Srikant
a S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS and Eisenbarth GS: Pre-type I diabetes. Linear loss of ß-cell response to intravenous glucose. Diabetes
1984; 33:717-720.
7.
Butle
r AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA and Butler PC: B-cell deficit and increased ß-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102-110.
8. Shimabukuro M, Zhou YT, Levi M and Unger RH: Fatty acid-induced ß-cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998; 95:2498-2502.
9.
Kharroub
i I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M and Eizirik DL Free fatty
ISSN:
2277-8713
IJPRBS
acids and cytokines induce pancreatic ß-cell apoptosis by different mechanisms: role of nuclear factor-kappa and endoplasmic reticulum stress. Endocrinology 2004;
145:5087-5096.
10. Goodner CJ, Koerker DJ, Weigle DS, McCulloch DK: Decreased insulin- and glucagon-pulse amplitude accompanying ß-cell deficiency induced by streptozocin in baboons. Diabetes 1989; 38:925-931.
11.
Bonner-Wei
r S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A and O'Neil JJ: In vitro cultivation of human islets from expanded ductal tissue. PNAS 2000;
97: 7999-8004.
12. Suzuki A, Zheng Y-W, Kaneko S, Onodera M, Fukao K, NakauchiH and Taniguchi H: Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. Journal of Cell Biology
2002; 156: 173-184.
13.
Le
e VM and Stoffel M: Bone marrow: an extrapancreatic hideout for the elusive pancreatic stem cell. Journal of Clinical
Investigation 2003; 111: 799-801.
14. Burns CJ, Minger SL, Hall S, Roderigo-Milne H, Ramracheya RD, Persaud SJ and
Jones PM: Generating insulin expressing cells from neural stem cells. Diabetologia
2003; 46: A174.
15. Hay CW, Docherty K: Comparative analysis of insulin gene promoters: implications for diabetes research.
Diabetes 2006; 55:3201-13.
16. Kojima H, Fujimiya M, Terashima T, Kimura H, Chan L: Extrapancreatic proinsulin/ insulin-expressing cells in diabetes mellitus: is history repeating itself? Endocrine journal 2006; 53:715-22.
17. Lifson N, Lassa CV, Dixit PK: Relation between blood flow and morphology in islet organ of rat pancreas. American Journal of Physiology 1985; 249:E43-8.
18. Samols E, Stagner JI, Ewart RB and Marks V: The order of islet microvascular cellular perfusion is B-A-D in the perfused rat pancreas. Journal of Clinical Investigation 1988; 82:350-3.
19. Ferrer J, Benito C, Gomis R: Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and
without NIDDM. Diabetes 1995; 44:1369¬74.
ISSN: 2277-8713
IJPRBS
20.
Butle
r AE, Janson J, Soeller WC, Butler PC: Increased ß-cell apoptosis prevents adaptive increase in ß-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 2003; 52:2304¬14.
21.
Butle
r AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: ß-cell deficit and increased ß-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;
52:102-10.
22.
Pipeleer
s DG, Pipeleers-Marichal M, Hannaert JC, Berghmans M, In't Veld PA, Rozing J, et al.: Transplantation of purified islet cells in diabetic rats. I. Standardization of islet cell rafts. Diabetes 1991; 40:08-19.
23.
Halba
n PA, Kahn SE, Lernmark A, Rhodes CJ: Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 2001; 10:2181-91.
24. Evans MJ, Kaufman MH: Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292:154-6.
Available Online At www.ijprbs.com
Review Article
Gajare SP, IJPRBS, 2012; Volume 1(4): 1-18
25. Colman A: Making new ß-cells from stem cells. Seminar Cell Development Biology 2004; 15:337-45.
26.
Lumelsk
y N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R: Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets 1.
Science 2001; 292:1389-94.
27. Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA: Insulin staining of ES cell progeny from insulin uptake. Science
2003; 299:363.
28. Hansson M, Tonning A, Frandsen U, Petri A, Rajagopal J, Englund MC: Artifactual insulin release from differentiated embryonic stem cells. Diabetes 2004;
53:2603-9.
29. Pedersen JK, Nelson SB, Jorgensen MC, Henseleit KD, FujitaniY, WrightCV:
Endodermal expression of Nkx6 genes depends differentially on Pdx1. Development Biology 2005;288:487-501.
30. Segev H, Fishman B, Ziskind A, Shulman M, Itskovitz-Eldor J: Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 2004; 22:265¬74.
ISSN: 2277-8713
IJPRBS
31. Brolen GK, Heins N, Edsbagge J, Semb H: Signals from the embryonic mouse pancreas induces differentiation of human embryonic stem cells into insulin-producing ß-cell-like
cells. Diabetes 2005; 54:2867-74.
32. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG: Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology 2006; 24:1392-401.
33. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL: Islet
transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosupressive regimen, New England Journal of Medicine 343 (4) (2000)
230-238.
34. Madsen OD, Serup P: Towards cell therapy for diabetes. Nature Biotechnology
2006; 24:1481-3.
35. Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of ß--cell mass in the growing rat pancreas, Estimation with a simple mathematical model. Diabetes1995;
44:249-256.
36. Adewumi O, et al.: Characterization of human embryonic stem cell lines by the
Available Online At www.ijprbs.com
Review Article
Gajare SP, IJPRBS, 2012; Volume 1(4): 1-18
International Stem Cell Initiative. Nature Biotechnology 2007; 25:803-16.
37. Vallier L, Alexander M, Pedersen RA: Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. Journal of Cell
Sciences 2005; 118:4495-509.
38. Fujikawa T, Oh SH, Pi L, Hatch HM,
Shupe T, Petersen BE: Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived
ISSN: 2277-8713
IJPRBS
insulin-producing cells. American Journal of Pathology 2005; 166:1781-91.
39. Korbutt GS, Mallett AG, Ao Z, Flashner
M,
Rajotte RV:
Improve
d survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation. Diabetologia 2004; 47:1810-8.
40. MorelliA AE, Thomson AW: Tolerogenic Dendritic Cells and the Quest For Transplant Tolerance. Nature Reviews Immunology
2007; 7:610-21.
Available Online
Thank you for copying data from http://www.arastirmax.com
